News
| Feb 04 | According to my analysis of $DNDN history with Full STO, we should move much higher soon http://chart.ly/lgcxnta by jman1204 |
| Feb 04 | BOA see's "Increased probability for success" with upgrading $DNDN HIGH demand for Provenge, higher prices soon, get in now..Rev= tripled. by ByHighSellHigher |
| Feb 04 | BOA see's "Increased probability for sucess" with upgrading $DNDN HIGH demand for Provenge, last Q tripled in Rev, stock is winding up. by ByHighSellHigher |
| Feb 04 | $DNDN really does look spring loaded for a run this month, chart is yummy by DoinWerk |
| Feb 04 | Beautiful Bull Flag and also a coil that's about to unwind. I would use caution shorting below $15. $DNDN http://chart.ly/rp2etsj by jettzero |
| Feb 04 | $DNDN http://stks.co/2FL6 Basing here nicely - Sneaky buy above $14.71, but breakout is clear above $15.21 by ChartSwingTrade |
| Feb 04 | $DNDN http://stks.co/2FKy Huge short interest and getting tight now. A big move is coming. See if clears 14.75 this week by traderstewie |
| Feb 03 | $SODA $DNDN $VRTX $ACHN $CLDX $IDIX Holding long, Great upside opp.....Patience, Patience.....Have GREAT weekend....Go Pats...!! by ByHighSellHigher |
| Feb 03 | $DNDN Printed an NR7, again. Last was 5 days ago... This thing is spring loaded. by onpaper |
| Feb 03 | What's Going on With These Biotech Stocks? |
| Feb 03 | This Just In: Upgrades and Downgrades |
| Feb 03 | Overreacting to a Prostate Cancer Drug? Investor Place |
| Feb 03 | Notable Analyst Rating Changes 02/03: (DNDN) (BBT) (NOV) Upgraded; (RIMM) (VRTX) (AET... |
| Feb 03 | Pre-Open Movers 2/3: (ZOLG) (GILD) (URBN) Higher; (THQI) (EW) (APKT) Lower (more...) Street Insider |
Profile
Exchange: NASDAQGM Sector: Healthcare Industry: Biotechnology
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Dendreon Corporation is down N/A over the last year vs S&P 500 Total Return up N/A, Human Genome Sciences down N/A, and Medivation up N/A.
- DNDN Total Returns
- ^SPXTR Total Returns
- HGSI Total Returns
- MDVN Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these DNDN related companies
Pro Strategies Featuring DNDN
Did Dendreon Corporation make it into our Pro Portfolio Strategies?
DNDN Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other DNDN Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Quote.com
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| DNDN | 14.17 | 0.23 | 1.65% | 2.11B |
| OPEN | 52.00 | 1.59 | 3.16% | 1.23B |
| TRLG | 36.18 | -0.04 | -0.11% | 931.63M |
| EZPW | 29.58 | 0.52 | 1.79% | 1.40B |
| SKS | 10.58 | 0.58 | 5.80% | 1.69B |
| FNSR | 21.59 | 1.20 | 5.89% | 1.96B |
| OVTI | 15.77 | 0.47 | 3.07% | 940.05M |
| PWER | 5.28 | 0.76 | 16.81% | 548.01M |
| SCHN | 45.56 | 1.21 | 2.73% | 1.24B |
| NFLX | 126.43 | 2.43 | 1.96% | 7.00B |
